LifeStance Health Group, Inc.LFSTEarnings & Financial Report
Lifestance Health (Lifestance) is an American outpatient behavioral health services provider. They provide their services in person and via tele-health. Their services include therapy, psychiatry, TMS, and ketamine therapies. They have landed in lawsuits multiple times over labor violations, leaking of customer information, and misleading investors.
Revenue
$325.5M
Gross Profit
N/A
Operating Profit
$1.1M
Net Profit
$-7.1M
Gross Margin
N/A
Operating Margin
0.3%
Net Margin
-2.2%
YoY Growth
16.0%
LifeStance Health Group, Inc. Q4 FY2024 Financial Summary
LifeStance Health Group, Inc. reported revenue of $325.5M (up 16.0% YoY) for Q4 FY2024, with a net profit of $-7.1M (up 84.2% YoY) (-2.2% margin).
Key Financial Metrics
| Total Revenue | $325.5M |
|---|---|
| Net Profit | $-7.1M |
| Gross Margin | N/A |
| Operating Margin | 0.3% |
| Report Period | Q4 FY2024 |
LifeStance Health Group, Inc. Annual Revenue by Year
LifeStance Health Group, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.4B).
| Year | Annual Revenue |
|---|---|
| 2025 | $1.4B |
| 2024 | $1.3B |
| 2023 | $1.1B |
| 2022 | $859.5M |
LifeStance Health Group, Inc. Quarterly Revenue & Net Profit History
LifeStance Health Group, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $382.2M | +17.4% | $11.7M | 3.1% |
| Q3 FY2025 | $363.8M | +16.3% | $1.1M | 0.3% |
| Q2 FY2025 | $345.3M | +10.6% | $-3.8M | -1.1% |
| Q1 FY2025 | $333.0M | +10.8% | $709.0K | 0.2% |
| Q4 FY2024 | $325.5M | +16.0% | $-7.1M | -2.2% |
| Q3 FY2024 | $312.7M | +19.0% | $-6.0M | -1.9% |
| Q2 FY2024 | $312.3M | +20.3% | $-23.3M | -7.5% |
| Q1 FY2024 | $300.4M | +18.9% | $-21.1M | -7.0% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $300.4M | $312.3M | $312.7M | $325.5M | $333.0M | $345.3M | $363.8M | $382.2M |
| YoY Growth | 18.9% | 20.3% | 19.0% | 16.0% | 10.8% | 10.6% | 16.3% | 17.4% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $2.11B | $2.12B | $2.11B | $2.12B | $2.10B | $2.15B | $2.15B | $2.20B |
| Liabilities | $677.3M | $689.3M | $670.8M | $672.0M | $647.6M | $672.9M | $656.2M | $682.9M |
| Equity | $1.43B | $1.43B | $1.44B | $1.45B | $1.46B | $1.47B | $1.49B | $1.52B |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-21.8M | $44.1M | $22.7M | $62.3M | $-3.1M | $64.4M | $27.3M | $57.6M |